
Mirixa offers customizable newsletter, RxFYI, free newsletter for pharmacies

Mirixa offers customizable newsletter, RxFYI, free newsletter for pharmacies

Predialysis patients can benefit from phosphate binders, an FDA advisory committee has decided.

Seattle pharmacist Beverly Schaefer has obtained funds to help pharmacies get involved in providing vaccinations.

S. Lawrence Kocot, former CMS adviser joins Sonnenschein Nath & Rosenthal

Confrontation with suicide bomber nets W.V. reservist an award for bravery.Confrontation with suicide bomber nets W.V. reservist an award for bravery.

Groups press for e-prescribing in Medicare.

Link suspected between diabetes drug, pancreatitis.

Apria Healthcare Group to acquire Coram.

FDA expands label for bortezomib (Velcade) for patients with impaired kidney function.

Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.

Topotecan granted FDA approval for relapsed small cell lung cancer.

Rite Aid and Lindora to expand California in-store clinics.

NABP awards DMEPOS accreditation to Walgreen Co.

Makers of homeopathic products push their cough and cold remedies in the wake of the withdrawal OTC cough and cold products for infants.

Although the number of independent pharmacies has decreased from 2006, salary levels for pharmacists and technicians have increased.

John Rector plans to step down from his position as general counsel for NCPA in 2008

Maryland pharmacists urge House Majority Leader Hoyer to put patients first

Medi-Promotions to launch Medi-Scripts Plus prescription pad

U.S. payers to incorporate biogeneric agents into their formularies

2008 Medicare Part D premiums to rise 21%, according to study by Avalere Health.

CVS Caremark celebrates American Pharmacists Month

Mipomersen sodium is the new generic name for Isis Pharmaceuticals' anticholesterol drug ISIS 301012.

Aetna's New Jersey e-prescribing pilot shows increase in generics

FDA launches initiative to bolster generic drug program

Changes are being evaluated in the value used to assess long-term glycemic control-moving from HbA1cto average blood glucose.